Back

Neutralizing efficacy of vaccines against the SARS-CoV-2 Mu variant

2021-09-26 infectious diseases Title + abstract only
View on medRxiv
Show abstract

The rise of mutant strains of SARS-CoV-2 poses an additional problem to the existing pandemic of COVID-19. There are rising concerns about the Mu variant which can escape humoral immunity acquired from infections from previous strains or vaccines. We examined the neutralizing efficacy of the BNT162b2 mRNA vaccine against the Mu variant and report that the vaccine has 76% neutralizing effectiveness against the Mu compared to 96% with the original strain. We also show that Mu, similar to the Delta...

Predicted journal destinations

1
Vaccines
131 training papers
Top 0.6% 10.7%
2
Scientific Reports
701 training papers
Top 48% 5.8%
3
PLOS ONE
1737 training papers
Top 78% 5.8%
4
Frontiers in Immunology
140 training papers
Top 3% 5.4%
5
Nature Communications
483 training papers
Top 22% 5.4%
6
Viruses
79 training papers
Top 0.5% 4.6%
7
Journal of Medical Virology
95 training papers
Top 3% 3.8%
8
Vaccine
140 training papers
Top 3% 3.5%
9
International Journal of Infectious Diseases
115 training papers
Top 5% 2.8%
10
Nature Medicine
88 training papers
Top 2% 2.5%
11
Journal of Infection and Chemotherapy
15 training papers
#1 2.5%
12
Clinical Infectious Diseases
219 training papers
Top 14% 1.9%
13
Science Translational Medicine
40 training papers
Top 1% 1.8%
14
The Journal of Infectious Diseases
137 training papers
Top 8% 1.8%
15
iScience
74 training papers
Top 6% 1.4%
16
Frontiers in Medicine
99 training papers
Top 13% 1.4%
17
Science
46 training papers
Top 3% 1.4%
18
JCI Insight
63 training papers
Top 5% 1.4%
19
Emerging Microbes & Infections
20 training papers
Top 0.3% 1.2%
20
eLife
262 training papers
Top 38% 1.2%
21
Med
26 training papers
Top 0.4% 1.2%
22
Cell Reports Medicine
49 training papers
Top 4% 1.2%
23
PLOS Pathogens
35 training papers
Top 2% 1.2%
24
The Lancet Infectious Diseases
57 training papers
Top 5% 1.2%
25
mBio
34 training papers
Top 1% 1.2%
26
New England Journal of Medicine
49 training papers
Top 2% 1.2%
27
Emerging Infectious Diseases
84 training papers
Top 13% 1.0%
28
Nature
58 training papers
Top 9% 0.9%
29
PLOS Medicine
95 training papers
Top 19% 0.9%
30
Cell
28 training papers
Top 2% 0.9%